Zum Inhalt

Revival of anti-angiogenic therapies in cancer

News from an old therapeutic concept—part 2

Erschienen in:

Auszug

Referring to the last issue presenting state of the art reviews [1] on the use of anti-angiogenic drugs in colorectal [2], urological [3, 4] and breast cancer [5] as well as in angiosarcomas [6], the present issue extends the topic to additional angiogenesis-dependent malignancies. Hereby, ovarian cancer and non-small cell lung cancer (NSCLC) represent two highly vascularized tumor entities where anti-angiogenic therapies form a robust backbone for the treatment of advanced stage disease mostly in combination with chemotherapy or newer therapeutic therapies. …
Titel
Revival of anti-angiogenic therapies in cancer
News from an old therapeutic concept—part 2
Verfasst von
Andreas Pircher, MD PhD
Publikationsdatum
27.02.2018
Verlag
Springer Vienna
Schlagwort
Onkologie
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2018
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-018-0394-0
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.